Dan - I can only go part way on your comment. I do believe our upward ride since October is two fold. I believe that the drop into the 4's was just too salivating and it matched Woodford's and Mehail's time frames. On the retail side, it was clearly Direct providing the propellant as many were still reeling from the trial expansion and the delayed interim report. The company's continued, well-managed march through Europe and the building of manufacturing was lost on most smaller positioned retails.
We are not getting to $20 without some substantial news. Your point about Direct being in a Phase 1 (safety) is well taken. Efficacy is best left to the Phase 2. However, the dribs and drabs of Direct news has whetted many on the retail side including me. It has raised the speculative value of the stock. I believe this to be Pyrr's point that though raised, it is not supported by unassailable results.
I am also concerned about the upcoming "L" interim results and am choosing to treat it as a binary event. If we get the halt for efficacy, I believe we are minimum $25. A continue drops us back to the 5's. An unlikely futility stop and . . .
I'm willing to give up the 8's even the 9's to protect against the 5's. I have been here too long and liquidated too many good positions for my over weight In NWBO. (For this long, I have to look at the time value of money.)
News 
Market Data 
Discover 
